HR Execs on the Move

Sight Sciences

www.sightsciences.com

 
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Ali Bauerlein
Chief Financial Officer Profile
Pete England
Vice President, Global Surgical Marketing Profile
Stacie Rodgers
Vice President Human Resources Profile

Similar Companies

Neal's Yard (Natural Remedies)

Neal's Yard (Natural Remedies) is a Stamford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VentriFlo

The VentriFlo True Pulse Pump is a novel, truly pulsatile blood pumping system designed to achieve superior outcomes, reduce costs and improve safety for pediatric & adult patients who require cardiopulmonary support during surgery or in the ICU.

Mindray North America

Mindray North America is a Mahwah, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orametrix

Orametrix is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Invendo Medical

Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on